Andrew Davis insider trades
Open-market stock purchases and sales by Andrew Davis, SVP, Chief Business Officer at Ironwood Pharmaceuticals Inc, from SEC Form 4 filings since Nov 21, 2022.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- IRWD Ironwood Pharmaceuticals Inc: 8 sales, last Nov 18, 2024